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Abstract
Recombinase alleles and transgenes can be used to facilitate spatio-temporal specificity of gene disruption or transgene
expression. However, the versatility of this in vivo recombination system relies on having detailed and accurate characterization of recombinase expression and activity to enable selection of the appropriate allele or transgene. The CrePortal (http://
www.informatics.jax.org/home/recombinase) leverages the informatics infrastructure of Mouse Genome Informatics to
integrate data from the scientific literature, direct data submissions from the scientific community at-large, and from major
projects developing new recombinase lines and characterizing recombinase expression and specificity patterns. Searching
the CrePortal by recombinase activity or specific recombinase gene driver provides users with a recombinase alleles and
transgenes activity tissue summary and matrix comparison of gene expression and recombinase activity with links to generation details, a recombinase activity grid, and associated phenotype annotations. Future improvements will add cell typebased activity annotations. The CrePortal provides a comprehensive presentation of recombinase allele and transgene data
to assist researchers in selection of the recombinase allele or transgene based on where and when recombination is desired.

Introduction
Along with individual research laboratories, large-scale
mouse gene targeting projects, such as KOMP, EUCOMM,
NorCOMM, and TIGM (collectively, the IKMC), have delivered a vast number of conditional-ready loxP-flanked alleles
to the scientific community (Skarnes et al. 2011; Bradley
et al. 2012). Many of these conditional-ready alleles from
large-scale projects are now available thanks to the efforts
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of programs such as the International Mouse Phenotyping
Consortium (IMPC) and the NIH-funded KOMP2 to turn
these stem cell resources into live mice (Ryder et al. 2014;
Dickinson et al. 2016; Birling et al. 2021). When combined
with a Cre-expressing allele, this system allows investigators to interrogate gene function through precise deletion
in a temporally and tissue-specific manner (Fig. 1) (Kim
et al. 2018). The value of this resource depends on the ready
availability of a large, diverse set of well-characterized Cre
driver lines and access to functional information about their
activity.
As of June 2021, Mouse Genome Informatics (MGI;
www.i nfor m atics.j ax.o rg) has data pertaining to 3299
recombinase alleles and transgenes driven by 1230 unique
promoters assayed in over 3718 tissues. Of the 3299
recombinase alleles and transgenes, 1166 are inducible.
Beyond the basic cre/lox system, temporally and spatially
restricted recombination can be achieved using different
recombinases (e.g., D6 site-specific recombinase, dre;
flp). Refinement of recombinase expression and activity
can be achieved using recombinases fused with inducible
elements (e.g., modified versions of the human estrogen
receptor, ESR*, ERT, or ERT2) (Feil et al. 2009; Kellendonk et al. 1996; Ludwig et al. 1996; Sauer et al. 2004) or
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Fig. 1  Cre recombinase in
genetics. A Cre recombinase
recognizes two repeated 34 bp
loxP sites in DNA, then excises
loxP-flanked sequences, leaving a single loxP site. More
complex rearrangements can
be made with changes to the
orientation and position of the
recognition sites. B To excise
sequences in vivo, a mouse
expressing Cre recombinase
under the control of a tissue
or temporal-specific driver is
crossed with a mouse carrying
LoxP sites that flank a gene
or genes of interest. Progeny
carrying both the loxP-flanked
gene and the Cre recombinase
will show deletion in the tissue
of interest at the stage when the
driver is expressed

a tetracycline response element combined with a transgene
expressing the reverse tet-transactivator (rtTA2; Dow et al.
2014). With the variety of tools, researchers can achieve
precise recombination to refine understanding alterations
in gene expression.
Characterization data that describe the timing and
distribution of recombination activity in mouse lines
are often fragmented in multiple publications, making it
challenging for users to find critical information for good
experimental design or to compare the relative utility of
different driver strains for a given application. The catalog of these available mouse strains has grown in recent
years. However, there are still significant gaps that limit
our ability to dissect gene function in certain tissue types
and developmental stages. Moreover, despite continued
advances and improvements in approaches to engineer
Cre driver lines, the fidelity of recombinase activity is
not always ideal. Limitations reported in the function
of various recombinase lines include expression in nontarget tissues (“off-target” activity), inconsistent activity,
incomplete or mosaic deletion in a target tissue/cell type,
and/or insertional mutagenesis (Heffner et al. 2012; Perry
et al. 2020). The CrePortal (http://www.informatics.jax.
org/home/recombinase) is a freely accessible public database that houses comprehensive information about existing
recombinase driver strains and their functional activity.
This includes integrated data curated from compiled literature about these lines and via direct submissions of characterization data from resource development programs,
providing the community with a comprehensive source
of recombinase driver tool strains and information about
them.
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Accessing data at the CrePortal web
interface
The CrePortal homepage (Fig. 2) offers users access to
recombinase allele and transgene data via a search form
and reports. In addition, the homepage provides links to
related searches of phenotypes, alleles and disease models or gene expression data. Frequently asked questions
point users to resources and strategies to identify their
desired recombinase allele or transgene, including a Cre
Portal tutorial. To identify annotated recombinase alleles
and transgenes, users can search the CrePortal based on
two parameters: anatomical structure and/or recombinase
driver.
Cre reporter data represent allele patterns created
through the tissue-specific activity of the Cre recombinase rather than gene expression patterns. However, from
a strictly technical point of view, Cre reporter data are
similar to knock-in reporter in situ data, a data type that
GXD has long captured (Smith et al. 2019; Baldarelli
et al. 2021). Therefore, the CrePortal takes advantage
of GXD infrastructure to record and search for recombinase activity patterns. Notably, it uses the mouse developmental anatomy (EMAPA) ontology developed by the
Edinburgh Mouse Atlas project (EMAP) and GXD (Hayamizu et al. 2015) to annotate the anatomical location
and developmental stage of Cre activity, thus enabling
hierarchical anatomical searches and the comparison of
Cre activity patterns (from the CrePortal) and expression patterns (from GXD) via interactive matrix views
(described further below). The EMAPA ontology is structured as a directed acyclic graph (DAG). The “abstract”

Annotated expression and activity data for murine recombinase alleles and transgenes: the…

Fig. 2  The CrePortal homepage supports searches using an anatomical structure or driver of expression or a combination of these parameters. Downloadable reports listing all recombinase alleles, the systems where activity is detected or not, and links to availability of the
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mouse strain are shown below the search boxes. Tutorials to assist in
answering specific research questions are listed on the right. Links to
help documents and other Cre resources are listed at the bottom of the
page (not shown)

Fig. 3  The EMAPA ontology
represents the mouse anatomy
for all developmental stages
(including postnatal stage TS
28) and specifies which anatomical structures exist at what
stages. The ontology is structured as a directed acyclic graph
(DAG) so that the anatomy can
be represented from different
hierarchical perspectives, such
as by organ system or by body
region. This allows for searching and data integration at different levels of resolution. For
more details on the ontology
and its structure, see Hayamizu
et al. (2015)
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representation of the anatomy is stage independent; each
term within this representation has attributes describing
the stage range in which that particular structure is present (Fig. 3). If a term (term A) is a direct part of another
term (term B) at any time, there is a subclass relationship
between these terms. Of note, the edge between term A
and term B is only valid during the intersection of the
stage ranges for these terms. For example, the heart atrium,
present from Theiler stage 15 through 28 (or adult), is a
part of the heart, which is present for more development
stages, Theiler stage 11 through 28. This representation
of anatomical structures allows for precise annotation of
recombinase activity to facilitate searches. GXD offers an
anatomy browser (http://www.informatics.jax.org/vocab/
gxd/anatomy) to help identify optimal anatomical terms
for searching. As well, the CrePortal search field contains
an autofill feature to assist in identifying the desired structure term. The EMAPA-directed acyclic graph structure
improves the likelihood of search success by returning all
results that are subclasses of the search term. A toggle on
the CrePortal search allows users to search by anatomical structures in which the recombinase activity has been
detected or assayed, allowing users, if they so choose, to
review the structures in which the absence of recombinase
activity has been demonstrated. The “and nowhere else”
check box allows users to narrow their search to reporters
whose activity has been detected in the specified structure
(or its substructures) but nowhere else.
Alternatively, the recombinase alleles and transgenes
can be searched for based on the driver used to produce

recombinase expression. These drivers include endogenous mouse promoters, exogenous once from other species, viral or bacterial promoters, and synthetic ones. Like
the recombinase activity search field, the recombinase
driven by search field offers an autofill function that lists
the matching drivers. The two search fields can be used in
conjunction to further refine the selection of recombinase
alleles and transgenes returned.
Results of queries by anatomical structure and/or driver
produce a summary table of the curator annotated data
within the CrePortal for a given recombinase allele or
transgene (Fig. 4). Columns contain the driver, allele symbol with link to the allele detail page, recombinase activity structures detected in, recombinase activity structures
not detected in, inducing agent (if applicable), link to the
International mouse Strain Resource (IMSR), link to associated references, and allele synonyms. Filter functions
allow users to limit the results by specific driver, inducer,
system detected in, or system not detected in. The result
columns also have alpha-numeric sort function.
In addition, a new matrix view that juxtaposes the
endogenous expression pattern of a gene (provided by
GXD) against activity patterns for recombinases driven
by that gene is now available (Fig. 5). This allows users to
anticipate recombinase activities in tissues not yet reported
for a particular driver of expression, and check whether
activity or expression of a particular line is as expected
compared to endogenous gene expression.

Fig. 4  Recombinase Allele-Tissue summary results for a search using
the anatomical structure ‘heart.’ Results fields include the driver,
allele symbol, recombinase activity structures detected in, recombi-

nase activity structures not detected in, inducing agent (if applicable),
link to the International Mouse Strain Resource (IMSR), link to associated references, and allele synonyms

13

Annotated expression and activity data for murine recombinase alleles and transgenes: the…

59

Fig. 5  Matrix view of Cre activity from Pcp2 driver lines compared
to endogenous gene expression. Shown are the activity assay data
for three recombinase-expressing lines utilizing the mouse Pcp2 promoter compared to endogenous Pcp2 gene expression. The EMAPA

mouse anatomy ontology is shown on the left and the toggles can be
opened and closed to view more substructures for a given system.
The red square indicates that activity was specifically assayed in a
system but not detected

Recombinase allele and recombinase
activity details

page, whereas it is closed by default, but can be expanded
via toggle, when the page is accessed via other search forms
available at MGI. Check marks indicate activity detected;
minus signs indicate confirmed absence of activity.
Tissue specificity information can be accessed by choosing an anatomical system in the expression summary grid
(Fig. 7). The recombinase detail pages have sortable data
columns indicating tissue structure, assayed age of specimen, pattern, level, reference, images if available, and assay
details with specimen assay notes. Users can resize each

Whether accessed through CrePortal search results or MGI’s
quick search field, specific, detailed information about individual recombinase alleles and transgenes is presented in
conjunction with an expandable grid of systems and structures versus time points derived from annotated recombinase
activity (Fig. 6). The recombinase activity grid is shown
open when the page is accessed via a CrePortal search results
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Fig. 6  Transgene detail page with opened recombinase activity table
and driver information. Expandable systems and structures activity table subdivided by stage ranges. Check marks indicate activity
detected; minus signs indicate confirmed absence of activity. When

available, links to images for the data are provided. A clickable button to report additional results or issues using this recombinase line is
provided at the bottom of the recombinase activity section

image and drag it anywhere on the page. This is especially
useful for side-by-side comparisons of expression in each
structure.

RESTful API, with client libraries in Perl, Python, Ruby,
Java, and JavaScript. Data are also available in tab-delimited
format from the CrePortal home page and the MGI reports
page (http://www.infor matics.jax.org/downloads/repor ts/
index.html#cre).
Finally, the CrePortal supports direct submission from
individual investigators and from projects of all images and
annotations, ensuring seamless access to all data alongside
curated results from the literature. A “Your Observations
Welcome” button is available at the bottom of the recombinase activity section of allele detail pages and can be used to
report additional activity or problems using the line (Fig. 6).
Submissions of novel activity and image data can be made
via our submissions form (http://www.informatics.jax.org/
mgihome/submissions/recombinase_submission.cgi) or by
bulk submission initially via MGI user support. Workflows
via programmatic submissions are handled on a case-by-case

Programmatic data access and data
submission
The CrePortal provides free public web access to data
from http://www.infor matics.jax.org/home/recombinase
as described above. CrePortal data access is also available
through MouseMine (http://w
 ww.m
 ousem
 ine.o rg) (Motenko
et al. 2015), an instance of InterMine that offers flexible
querying, templates, and iterative querying of results that
are integrated with other mouse data provided by MGD and
GXD. MouseMine also links to other model organism InterMine instances. MouseMine access is also available via a
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Fig. 7  Recombinase activity details with expandable and draggable
images. Shown is a cardiovascular system activity detail page for
mice expressing Cre under the control of a human ACTA1 driver. In
addition to molecular details and availability of mice, other alleles
with activity in the cardiovascular system are available as a list.

Images are shown and can be expanded by dragging a gray corner of
the image and moved to other regions of the page. Activity details
include the structure, age, level, and pattern of the detected activity.
Assay methods, genotype background, and individual results notes
related to the annotation are available by clicking on the tab buttons

basis and include the submission of Cre characterization
data from the JAX Cre Repository.

or mosaic deletion activity has been observed (Lu et al.
2008; Means et al. 2005; Pilon et al. 2008) and inducible
Cre driver lines, typically estrogen receptor ligand binding
domain fusions, can present similar challenges (Feil et al.
1997; Indra et al. 1999; Metzger and Chambon 2001) including leakiness (Balordi and Fishell 2007). In addition, we
have reported a phenomenon of widespread, but inconsistent, activation in Cre lines that otherwise display specific
activity (Heffner et al. 2012). The engineering approach
used to generate a given Cre driver can impact function.
For example, transgenics can suffer from integration sitemediated alteration of expression levels and patterns, copy
number instability, insertional mutagenesis, and epigenetic
silencing of the transgene (Matthaei 2007). We and others
have recently shown insertional mutagenesis is common, and
this is accompanied by structural rearrangements and/or cointegration of unexpected/unreported passenger sequences
(Goodwin et al. 2019; Cain-Hom et al. 2017), which can
affect Cre function or the expression of genes at or near the

Systematic characterization
of recombinase‑expressing mouse lines
A significant part of the data in the CrePortal comes from
projects that perform a systematic characterization of recombinase-expressing mouse lines, including our work as part
of the JAX Cre Repository. Despite the power and versatility of cre driver strains, full awareness and consideration
of the caveats and limitations to their use are critical for
good experimental design (Schmidt-Supprian and Rajewsky
2007). We (Heffner et al. 2012) and others (Eckardt 2004;
Lan et al. 2007; Kucherlapati et al 2006) have shown that
Cre lines can exhibit “off-target” activity, that is excision
activity in domains not intended or expected based on the
predicted function of the driver construct. Inconsistent and/
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integration site (Laboulaye et al. 2018). Targeting Cre to a
specific locus and thus assuring full endogenous regulatory
context can improve the fidelity of expression, but haploinsufficiency at a particular locus could confound interpretation of phenotypes if the driver gene is related to the gene
or phenotype being investigated (Eagleson et al. 2007). Cre
expression in the germline, most commonly the female germline, can impact the degree of excision activity or trigger
widespread activation (Gallardo et al. 2007; Lomeli et al.
2000). Together, these observations illustrate the need for
systematic evaluation and reporting of Cre driver function
and caveats to assure the reliability and reproducibility of
studies using these powerful tools.
For highly used lines, the extensive literature provides
a reasonably complete picture of the on-target (intended)
activity, but frequently this does not include a full assessment of activity in non-target tissues. Existing Cre lines are
often used for entirely new research purposes, and depending

on the experiment, off-target activity might confound interpretation of results. Therefore, the widespread adoption
of individual Cre lines as generalized tools further necessitates systematic evaluation of all potential recombinase
actively. Because JAX is the single largest distributor of Cre
driver strains, with several hundred unique lines available,
we have built an efficient and high-throughput workflow to
systematically assess Cre driver functionality using a sensitive reporter strain and characterizing activity in a broad
range of tissues at multiple time points (Heffner et al. 2012).
Summarized in Fig. 8, the pipeline has been refined to focus
on two developmental time points (embryonic days 10.5
and 15.5) and a single adult time point (8 weeks/56 days).
For adults, both males and females are included to capture
activity in sex-specific organs, including the gonads. Whole
E10.5 embryos are LacZ stained, while fresh frozen cryosections are processed and stained for E15.5 embryos and adult
tissues. To balance throughput with the need for a broad

Fig. 8  JAX cre driver characterization pipeline. A Summary of pipeline illustrating the use of a LacZ reporter and characterization of
three timepoints: adult, E15.5, and E10.5. For inducible lines, tamoxifen is used to activate Cre activity in adult cre/reporter F1 animals,
or in pregnant reporter females for embryonic time points. Whole
mount staining is performed on E10.5 embryos, which are then seri-

ally sectioned. For E15.5 and adult time points, fresh frozen sections
are stained and slides with positive staining are scanned and annotated. All data are submitted to the CrePortal. B Illustration of results
from adult samples showing both on-target and off-target activity for
commonly used Cre lines. C Illustration of variable activity for three
embryos from the same Cre line
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assessment, we have selected a standard set of 55, 90, and
65 structures for E10.5, E15.5, and adult tissues, respectively. Our use of colorimetric staining allows for a streamlined workflow that includes full slide scanning, which are
annotated to anatomical terms where positive staining is
observed. Systematic characterization has revealed unexpected/off-target recombination in many Cre alleles in
common use (example in 7B), which may confound their
use for specific research questions. Moreover, the pipeline
has uncovered additional caveats and challenges that could
influence the interpretation of results, including variable
widespread activation in some individuals (Fig. 8C) (Heffner et al. 2012). Ultimately, our unbiased approach allows
individual investigators to determine whether these off-target
and/or unexpected effects would influence their approach,
including modification of their experimental design (e.g.,
different driver, additional controls) to account for the limitations of a given strain.

Discussion
The development of conditional-ready alleles for spatio-temporal or inducible gene knock-out or transgene expression
has expanded our knowledge of gene function in the context of both anatomical structure and developmental stage.
The ever-increasing availability of recombinase-expressing
alleles and transgenes are limited in their usefulness by
the inability of researchers to select the optimal recombinase allele or transgene based on their activity patterns and
potential phenotypic impact absent complete characterization of the recombination activity. The CrePortal provides
an invaluable resource to identify and evaluate the potential
location and time of recombination for suitability in a given
experiment depending on the researcher’s hypothesis. The
availability of both summarized and detailed recombinase
activity data with comparison to driver gene expression patterns gives researchers a complete and searchable context for
annotated and expected recombinase activity. Furthermore,
the CrePortal supports direct submission of data reporting recombinase activity, simplifying centralized access to
large-scale Cre driver generation and/or characterization
programs.
Future directions for the CrePortal include the retrieval of
data associated with specific cell types and improved search
and visualization tools. For example, the current anatomical
tissue search will not support a search for “Purkinje cell,”
an output cell of the cerebellar cortex. The Grid2 and Pcp2
gene drivers express recombinase in Purkinje cells but are
annotated to “Purkinje cell layer” in the CrePortal; however,
additional cell types exist in this tissue. Furthermore, the
striatonigral and striatopallidal projection neurons in the
striatum of the brain selectively express the Drd1 and Drd2
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dopamine receptors, respectively (Gong et al. 2007). However, mouse lines expressing recombinases under the control of these drivers are both annotated to the tissue “corpus
striatum,” obfuscating the cell type specificity of these drivers within this tissue. We will use the Cell Ontology (Diehl
et al. 2016) to annotate cell-specific activity in conjunction
with anatomical location.
As the number of Cre lines and data continue to increase,
it is imperative that there are effective visualization tools
to assist with effectively sorting through available information. We will develop additional search and display tools to
provide data as aggregate comparisons, with the ability to
drill down to specific characterization data. For example, a
differential search for a Cre line with expression in tissue X
at mid-gestational age and NOT in adult or vice versa may
be useful to observe changes in a temporal manner or to
study changes in adult tissues when expression in embryo
tissues may result in lethality. This will require the addition of developmental stage-specific search capabilities for
Cre activity at the portal, similar to the GXD Differential
Expression Search interface. We will continue to develop
new search and visualization tools as new technologies arise.
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